Cap. Zinfo
Capsule · PO · (500mg + 22.5mg) · 1 capsule
৳3
Cap.
Zinfo
Folic Acid + Zinc Sulfate Monohydrate
— Marker Pharma Ltd.
(500mg + 22.5mg)
Presentations
Dose rules
No structured dose rules are linked to this brand yet.
Dose reference
Human
Orally 1 tablet daily or as directed by the physician.
Clinical notes
Applications:
N/A
Indication Notes:
This tablet is indicated for the treatment and prophylaxis of Folic Acid and Zinc deficiencies.
Avoid In:
N/A
Contraindication Notes:
Zinc is contraindicated in patients having hypersensitivity to Zinc. Folic Acid is contraindicated in untreated cobalamine deficiency
This tablet is a special preparation of Folic Acid & Zinc Sulfate Monohydrate. Zinc is an essential trace element required for human nutrition and involved in a number of body enzyme system. Severe Zinc deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility of infections, cognitive impairment, etc. Folic Acid is a member of the B-Vitamins group. It is reduced in the body to tetrahydrofolate, which is the coenzyme for various metabolic processes including the synthesis of purine and pyrimidine nucleotides, and hence the synthesis of DNA. It is also involved in some amino acid conversions. Deficiency of Folic Acid may cause megaloblastic anaemia, develops when the dietary intake is inadequate, as in malnutrition, from malabsorption, from increased utilization as in pregnancy of conditions such as haemolytic anaemia, and as a result of administration of folate antagonists.
A large amount of Calcium decreases the absorption of Zinc. In case of Folic Acid, no drug interactions have been reported.
Folic Acid & Zinc is well tolerated in the recommended dose. Occasionally gastrointestinal disturbances like abdominal pain, dyspepsia, nausea, vomiting, fever and respiratory distress may occur.
Zinc Sulfate is corrosive in overdose. Symptoms are corrosion and inflammation of the mucous membrane of the mouth and stomach.
Recommended during pregnancy & lactation.